missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ Human METTL12 (aa 164-234) Control Fragment Recombinant Protein

Numéro de catalogue. RP97571
Modifier l'affichage
Click to view available options
Quantité:
100 μL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Numéro de catalogue. Quantité
RP97571 100 μL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Numéro de catalogue. RP97571 Fournisseur Invitrogen™ Code fournisseur RP97571

Recombinant Protein

Highest antigen sequence indentity to the following orthologs: Mouse (25%), Rat (25%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-58252 (PA5-58252. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.

Spécifications

Numéro d'enregistrement A8MUP2
Concentration ≥5.0 mg/mL
À utiliser avec (application) Blocking Assay, Control
Formule 1 M urea, PBS with no preservative; pH 7.4
ID du gène (Entrez) 751071
Nom Human METTL12 (aa 164-234) Control Fragment
Quantité 100 μL
Statut réglementaire RUO
Alias du gène Citrate synthase-lysine N-methyltransferase CSKMT, mitochondrial; CSKMT; CS-KMT; methyltransferase like 12; methyltransferase-like protein 12, mitochondrial; METTL12; Putative methyltransferase LOC751071, mitochondrial; U99HG
Nom usuel METTL12
Symbole de gène CSKMT
Conjugué Unconjugated
Espèces Human
Recombinant Recombinant
Étiquette de la protéine His-ABP-tag
Séquence GTWDAVARGGLPRAYQLLSECLRVLNPQGTLIQFSDEDPDVRLPCLEQGSYGWTVTVQELGPFRGITYFAY
Contenu et stockage -20°C, Avoid Freeze/Thaw Cycles
Système d’expression E. coli
Forme Liquid
Grade de qualité ou de pureté >80% by SDS-PAGE and Coomassie blue staining
Afficher plus de résultats Afficher moins de résultats